Older Cannabis Users: Benefits for Dispensaries, Concerns for Doctors
Older adults cannabis dosing safety is a growing concern as this demographic increasingly uses cannabis. Clinicians face challenges due to limited safety data and drug interactions. Understanding these issues is vital for appropriate patient counseling.
AM Policy Update: DEA Scheduling and Cannabis Rescheduling March 16, 2026
The DEA scheduling cannabis rescheduling update on March 16, 2026, highlights key regulatory changes affecting cannabis medicine. This includes the temporary placement of several substances in Schedule I and the proposed rescheduling of marijuana. These…
Cannabis Research Clinical Update: March 16, 2026
This cannabis research clinical update from March 16, 2026, summarizes 20 key studies from PubMed prioritized by clinical relevance. The update covers evidence on cannabis for chronic pain, anxiety, and adolescent health. Clinicians will find valuable…
Cannabis Use by Older Adults: Risks and Insights 2026
Cannabis use by older adults is increasingly common and raises important questions about mental decline risks. This update reviews recent findings on cognitive effects and safety concerns. Understanding cannabis use by older adults helps guide clinical…
New Group Launches Ahead of Medicare CBD Pilots
Medicare CBD pilot programs represent a pivotal step in federal recognition of cannabis-derived therapeutics. These programs aim to generate clinical efficacy data for CBD in Medicare beneficiaries. The outcomes could influence future coverage and…
Cannabis Compounds Fatty Liver Clinical Relevance in 2026
This CED Digest highlights cannabis compounds fatty liver clinical relevance with 230 curated items for clinicians. CBD and CBG show potential therapeutic effects on fatty liver disease. These findings offer evidence-based insights for patient care in…
As a Medical Cannabis Patient, I’m Watching This Supreme Court Case Closely
The supreme court medical cannabis case has significant implications for patient legal protections. This case could affect state medical cannabis programs and patient access. Clinicians and patients alike should monitor this evolving legal landscape…
AM Policy Update: March 15, 2026
The DEA scheduling cannabis policy update on March 15, 2026, highlights key regulatory changes affecting cannabis medicine. This includes temporary placements and rescheduling of substances relevant to controlled substances regulations. Understanding…
Cannabis Clinical Trials Evidence: March 15, 2026 Update
This AM Study Update presents cannabis clinical trials evidence from March 15, 2026, focusing on recent research findings. The report covers safety and efficacy data for various cannabis therapies. Clinicians can use this evidence to inform patient care…
Cannabis News Update: March 15, 2026 Highlights
This cannabis news update for March 15, 2026, covers key developments in cannabis research and legislation. Highlights include studies on CBD and CBG for fatty liver disease and regulatory updates. Stay informed with the latest cannabis news update…